Sponsor
National Institute of Cancerología
Clinical research sponsor
Clinical trials
11 shownUse of Clorhexidine Dressings to Reduce Surgical Site Infections in Breast Cancer Surgery. A Controlled Clinical TrialNCT03229824 · lead sponsor · 2016-10-03
COMPLETEDImpact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.NCT03296553 · lead sponsor · 2015-10-01
COMPLETEDEffect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response BiomarkerNCT01041833 · lead sponsor · 2010-01-01
UNKNOWNEffect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung CancerNCT01048970 · lead sponsor · 2009-10-01
UNKNOWNGene-expression Profiles in CNS-metastatic Non-small Cell Lung CancerNCT00862173 · lead sponsor · 2008-03-01
UNKNOWNEffect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung CancerNCT01048645 · lead sponsor · 2007-09-01
COMPLETEDTherapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung CancerNCT01052818 · lead sponsor · 2007-07-01
UNKNOWNPalliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural MesotheliomaNCT00886028 · lead sponsor · 2006-09-01
UNKNOWNConcurrent Chemotherapy and Radiotherapy With Nitroglycerin in Patients With Locally Advanced Non-Small Cell Lung CancerNCT00886405 · lead sponsor · 2006-07-01
UNKNOWNHydralazine and Valproate Added to Chemotherapy for Breast CancerNCT00395655 · lead sponsor · 2005-06-01
TERMINATEDK-RAS Oncogene Mutation in Patients With Advanced Non-Small Cell Lung Cancer Associated With Exposure to Wood Smoke and Tobacco Smoking: Therapeutic ImplicationsNCT01023828 · lead sponsor · 2005-04-01
COMPLETEDSponsor roles
lead sponsor11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.